NEU neuren pharmaceuticals limited

Ann: Update on development plan for NNZ-2591, page-3

  1. 2,981 Posts.
    lightbulb Created with Sketch. 643
    If things turn out OK with the phase 3 trofinetide trial, then NEU can go all the way with 2591 on their own - huge considering their expectations for the second arrow in their quiver.
    Last edited by Mr_Cod: 26/04/19
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.